MedTrace Logo

Age Gene/Environment Susceptibility Reykjavik Study

NCT03269656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5764

Last updated 2017-09-01

No results posted yet for this study

Summary

5764 men and women in Iceland, aged 66 to 96 years entered the Ages Gene/Environment Susceptibility (AGES) - Reykjavik Study. Serum 25(OH)D was measured in 5,519 of all 5,764 (96%) participants at study entry in year 2002 through 2006. The main emphasis was on exploring whether pre-diagnostic serum levels of 25(OH)D were associated with survival after cancer diagnosis.

Conditions

  • Neoplasms

Sponsors & Collaborators

  • University of Iceland

    collaborator OTHER

  • Icelandic Heart Association

    lead OTHER

Principal Investigators

  • Johanna Torfadottir, PhD · University of Iceland

Eligibility

Min Age
66 Years
Max Age
98 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-01
Primary Completion
2006-01-31
Completion
2014-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03269656 on ClinicalTrials.gov